Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. Optum to pick up LHC Group Though […]
More hospitals and health systems are stepping into the home-based hospice space, often seeing joint ventures as a promising route to a return on their investment. While there are several factors driving facility-based health care organizations to eye home-based care, more than anything, hospices and other providers should simply be aware that the “normal” look […]
In its calculus behind its 2021 Kindred at Home deal, Humana Inc. (NYSE: HUM) had to weigh the potential cost savings and lucrative hospice divestiture against the labor pressures in the space, as well as the complexity of scaling home-based care in a fragmented industry. Last year, Humana acquired total ownership of Kindred at Home […]
Mergers-and-acquisition activity continues to boom in the hospice space this year. Deal volume may exceed the record number from the prior two years. As many as 61% of the 203 hospice care professionals who responded to a recent Hospice News Outlook Survey and Report said they anticipate that hospice M&A activity will increase during 2022. […]
Private equity and venture capital investors continue to flock to the hospice space. When negotiating with investors that are new to the industry, providers in some cases are coming to the table with parties that are not familiar with the regulatory environment, even as federal enforcement activity ramps up. Of the 23 hospice-related deals in […]
Mergers-and-acquisition activity in the hospice market has run hot in recent years, with valuations reaching another year of record-highs in 2021. Meanwhile, private equity activity hit record levels as well, with an affluence of investors that flowed into hospice waters during 2021. Despite these factors, the market may be cooling down this year as investors […]
The hospice merger and acquisitions market has been running hot, with activity showing no signs of cooling as 2022 kicks off. Even so, intensifying regulatory pressure could lead a larger contingent of smaller providers to sell, further stimulating the market. M&A activity in the home health and hospice spaces outpaced other health care service sectors […]
Amedisys (NASDAQ: AMED) will be honing its acquisitional focus more towards the home health care space heading into next year. Soaring valuations in hospice, along with a crowded market and the complexity of integrating these assets are among the factors pulling the company’s gaze, according to CEO Paul Kusserow. The hospice merger and acquisitions market […]
Merger and acquisition activity in the hospice and home health care space has been exploding in recent years as investors from all walks dive into these markets. Hospice deals have been moving forward at a record pace. As providers contend with widespread workforce shortages, buyers are paying close attention to leadership teams, staffing levels and […]
LHC Group (NASDAQ: LHCG) aims to continue growth of its hospice services as this year unfolds with a number of acquisitions in the works. Record-high multiples for hospice acquisitions are not deterring LHC Group from pursuing those transactions. Hospice deals accounted for 71% of the $502.5 million the company currently earmarked for its M&A pipeline. […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
